<DOC>
	<DOCNO>NCT01006421</DOCNO>
	<brief_summary>Vitiligo common chronic skin disease 1-4 % prevalence . It significant psychosocial impact patient society . Different treatment modality variable success rate available . Phototherapy among successful treatment give modest result . Some report document usefulness Ginkgo Biloba ( GB ) use alone Vitiligo treatment .</brief_summary>
	<brief_title>Oral Ginkgo Biloba Narrow Band UVB Treatment Vitiligo</brief_title>
	<detailed_description>Adding GB phototherapy , especially commonly used one ; Narrow-Band UVB ( NBUVB ) might give good result use either one alone . This might improve repigmentation well patient ' quality-of-life . ( QOL ) . This prospective double-blind randomize controlled clinical trial . One-hundred-sixty Vitiligo patient randomly divide 2 group ( 80 patient per group ) . One group receive oral GB ( 2 tablet 60 mgs twice daily ) NBUVB twice weekly . The group receive placebo tablet ( identical size , shape color ) GB twice daily NBUVB twice weekly . Both group treat 6 month . Standard protocol phototherapy use group . Our aim see whether add GB NBUVB lead good repigmentation placebo .</detailed_description>
	<mesh_term>Vitiligo</mesh_term>
	<criteria>Any Vitiligo patient ( age 12 year ) nonsegmental Vitiligo . Body surface area ( BSA ) involvement â‰¥ 3 % . Unable consent Any topical , systemic phototherapy Vitiligo previous 2 month . Pregnancy , breast feeding . Liver kidney disease . Epilepsy Bleeding disorder anticoagulant treatment</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>phototherapy</keyword>
	<keyword>Gingko biloba</keyword>
	<keyword>repigmentation</keyword>
</DOC>